Almost all wealthy countries except the US, use a single payer system where the government sets the price of drugs.
> And what is the "fair and free" price of insulin?
Free as a victim of diabetes, some marginal cost to the countries budget based on a negotiation with the pharma company.
Typically, because the country has enough scale, it is cost effective for the government to design and estimate costs for a government run facility to produce the drug and use that as a bargaining chip including if needed voiding the IP rights of that foreign entity for national defense reasons.
> Typically, because the country has enough scale, it is cost effective for the government to design and estimate costs for a government run facility to produce the drug and use that as a bargaining chip including if needed voiding the IP rights of that foreign entity for national defense reasons.
You got a link about that because I am super interested to read into that more. I believe india doesn't respect medical IP but I'm surprised first world countries that produce medical IP do and that the US apparently isn't ripping off foreign countries medical IP who do that in retaliation.
I haven't cross checked it, but it seems to state similar things to what I've heard before, like “compulsory licensing” which was only un-done because of NAFTA, but that just means its a political bargaining chip that is not currently cashed.
I'm sure other countries have different rules, Canada is more beholden to the US than any other country.
Almost all wealthy countries except the US, use a single payer system where the government sets the price of drugs.
> And what is the "fair and free" price of insulin?
Free as a victim of diabetes, some marginal cost to the countries budget based on a negotiation with the pharma company.
Typically, because the country has enough scale, it is cost effective for the government to design and estimate costs for a government run facility to produce the drug and use that as a bargaining chip including if needed voiding the IP rights of that foreign entity for national defense reasons.